Title: International Trade and the Global Pipeline of New GM Crops
Authors: STEIN Alexander JivrajRODRIGUEZ CEREZO Emilio
Citation: NATURE BIOTECHNOLOGY vol. 28 no. 1 p. 23-25
Publisher: NATURE PUBLISHING GROUP
Publication Year: 2010
JRC N°: JRC54604
ISSN: 1087-0156
URI: http://www.nature.com/nbt/journal/v28/n1/suppinfo/nbt0110-23b_S1.html
http://publications.jrc.ec.europa.eu/repository/handle/JRC54604
DOI: 10.1038/nbt0110-23b
Type: Articles in Journals
Abstract: In a Correspondence in the August issue, Graff and colleagues (2009) sought to answer the question of why quality-improving innovations from agbiotech have not been more readily forthcoming, and through a survey carried out in 2004 they identified 49 quality innovations expected to be commercialized by 2015 (21 of those between 2010 and 2015). Clear-sighted, they cautioned that attribution during regulatory review and commercialization will probably mean only a fraction of these 49 reaches the market. In a similar but more recent exercise we compiled a global pipeline of new GM crops, in which a total of 91 new GM crops are expected to be commercialized between 2009 and 2015 ¿ of which only 18 represent quality innovations.
JRC Institute:Institute for Prospective Technological Studies

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.